Version history

{
  "session_id": "fea-27014558ee0c",
  "round_number": 1,
  "agent_persona": "persona-evidence_auditor",
  "action": "audit_evidence",
  "content": "\n\nBased on the information provided, I cannot perform a comprehensive audit because the actual pathway diagram for GPR37 was not included in your query. However, I can provide a preliminary assessment based on the claim and typical characteristics of pathway diagrams.\n\n## Evidence Audit\n\n**1. Relevance**\nPathway diagrams showing GPR37 signaling could theoretically support a microglial-amyloid-cytokine activation model if the diagram explicitly depicts connections between GPR37, amyloid interaction, and cytokine modulation in microglia. Without seeing the actual figure, relevance cannot be confirmed.\n\n**2. Statistical Rigor**\nPathway diagrams are inherently schematic representations of biological relationships and typically do not include statistical metrics such as p-values, confidence intervals, or effect sizes. This is a fundamental limitation when using pathway diagrams as evidence for causal claims.\n\n**3. Sample Adequacy**\nNot applicable — pathway diagrams do not convey sample size or experimental replicates.\n\n**4. Reproducibility Indicators**\nA single pathway diagram does not provide replication or validation data. Independent experimental confirmation would be required.\n\n**5. Confounds**\nPathway diagrams do not address confounding variables or alternative explanations.\n\n**Key Concerns:**\n- Pathway diagrams represent hypothetical mechanisms, not empirical evidence\n- No statistical data to support causal claims\n- Cannot verify if GPR37 pathway specifically addresses microglial-amyloid-cytokine axis\n- Missing experimental validation data\n\n**Preliminary Verdict:** Without the actual figure, this assessment cannot definitively evaluate the evidence. Pathway diagrams alone generally provide weak support for activation models, as they illustrate hypothesized relationships rather than experimental findings.\n\n{\"evidence_score\": 0.25, \"relevance\": \"moderate\", \"statistical_rigor\": \"weak\", \"key_concerns\": [\"Pathway diagrams lack statistical evidence for causal claims\", \"Cannot verify specific microglial-amyloid-cytokine connections without figure content\", \"No sample size or replication data available\", \"Schematic representations cannot replace experimental validation\"], \"preliminary_verdict\": \"does_not_support\"}"
}